Product features

  • High-performance ELISA kits with guaranteed stability and lyophilized conjugates when necessary.
  • G/M presentation allows flexible IgG and IgM testing combinations within a single kit.
  • Direct in-well sample dilution and sorbent treatment when required.
  • Colour-coded, ready-to-use liquid reagents and individual break-apart wells.
  • Suitable for flexible manual or automated processing.
Kit ELISA

PRODUCTS

MUMPS ELISA IgG/IgM

CE
Indirect immunoenzyme assay to test IgG and/or IgM antibodies against mumps virus in human serum/plasma.

Analytes: Mumps

Reference G/M1014
Pack size 96 tests

MORE RESOURCES

Virus/Bacterias
RELATED VIRUSES/BACTERIA

Related germs and organisms categorized for this product line.

Flyers
FLYERS

Downloadable PDF materials, brochures, and technical documents.

Blog
BLOG

The latest insights, news, and research articles from our scientific team.

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular
02 July 2026

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular

Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...

Beyond detection: H. pylori testing in today’s laboratory workflow
26 June 2026

Beyond detection: H. pylori testing in today’s laboratory workflow

Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis
15 May 2026

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis

Invasive aspergillosis is still one of the most difficult fungal infections to diagnose early. It mainly affects patients with weakened immune systems...

Bibliography
BIBLIOGRAPHY

Scientific bibliography and references related to this product.

Ghafoori F, Mokhtari-Azad T, Foroushani AR, Farahmand M, Shadab A, Salimi V. Assessing seropositivity of MMR antibodies in individuals aged 2–22: evaluating routine vaccination effectiveness after the 2003 mass campaign—a study from Iran’s National Measle
Saffar H, Mousavi SJ, Saffar H, Parsaei MR, Ghorbani GR, Saffar MJ. Seroconversion rates following 2 doses of measles- mumps- rubella vaccination given at the ages 12 and 18 months: data for possible additional dose at older age. BMC Immunology. 2022 Dec
Saffar H, Mousavi SJ, Saffar H, Shiraj H, Mohammed-Jafar S. Seroimmunity status to Measles-Mumps-Rubella-Varicella-Pertussis- Diphtheria -Tetanus among Students Accepted to Mazandaran University of Medical Science, Sari, North of Iran, 2018-2019: Planning